Detail akcie Teleflex online

Business Summary: Teleflex Incorporated is a global provider of medical technology products. The Company offers a diverse portfolio of solutions in the therapy areas of anesthesia, emergency medicine, interventional cardiology and radiology, surgical, vascular access, and urology. It primarily designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. It operates in three segments: the Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). Its vascular access product portfolio includes Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous (bone access) systems. Interventional product offerings consist of a portfolio of Arrow branded intra-aortic balloon pumps and catheters, GuideLiner, Turnpike and TrapLiner catheters, the MANTA Vascular Closure device and Arrow OnControl powered bone biopsy system.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2024, Teleflex Inc revenues increased 2% to $3.05B. Net income before extraordinary items decreased 80% to $70.2M. Revenues reflect EMEA segment increase of 5% to $618M, Americas segment increase of 1% to $2.07B, Europe segment increase of 6% to $705.1M, Asia Pacific segment increase of 6% to $326.4M. Net income was offset by Pension settlement charge increase from $45.2M to $132.7M (expense), Selling.